Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2022 Publisher: Cephalon UK Limited, Ridings Point, Whistler Drive, Castleford, West Yorkshire, WF10 5HX, United Kingdom
Gabitril 10 mg film-coated tablets.
| Pharmaceutical Form |
|---|
|
10 mg: Tablet. White, oval biconvex film-coated tablet embossed on one side with ‘252’. |
Each Gabitril 10 mg tablet contains: Tiagabine anhydrous, INN 10 mg (as hydrochloride monohydrate).
Excipient(s) with known effect: For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Tiagabine |
Tiagabine is an anti-epileptic drug. Tiagabine is a potent and selective inhibitor of both neuronal and glial GABA uptake, which results in an increase in GABAergic medicated inhibition in the brain. |
| List of Excipients |
|---|
|
Tablet Core: Cellulose, microcrystalline (E460) Film-coating: Hypromellose |
Child resistant, white polyethylene bottles with white polypropylene screw closures with an embedded desiccant agent.
Packs containing 50 and 100 tablets. Not all pack sizes may be marketed.
Cephalon UK Limited, Ridings Point, Whistler Drive, Castleford, West Yorkshire, WF10 5HX, United Kingdom
PL 16260/0010
Date of first authorisation: 30th September 2002
Date of latest renewal: 31th August 2006
| Drug | Countries | |
|---|---|---|
| GABITRIL | Australia, Spain, France, Ireland, Lithuania, Poland, United Kingdom, United States |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
